Patents Examined by Michail A. Belyavaskyi
  • Patent number: 7204978
    Abstract: A method of treating an infertility condition in humans or mammals, by exposure of a prospective mother to TGF beta or derivative or analog of TGF beta. The exposure is advantageously in conjunction with one more antigens of a prospective father so that a hyporesponsive immune reaction is mounted to the one or more antigens of the prospective father.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: April 17, 2007
    Assignee: The University of Adelaide
    Inventors: Sarah Anne Robertson, Kelton Paul Tremellen